Innovative drugs mark the ‘before’ and ‘after’ of the approach to fighting cancer
“The use of new cancer drugs during this period reduced cancer deaths in Spain by almost 30%, by more than 42,000 people,” said Frank R. Lichtenberg, a professor at Columbia University.
Professor Frank R. Lichtenberg, Professor of Economics at Columbia University (USA), analyzed the relationship between pharmaceutical innovation and cancer mortality in Spain over a period of more than 15 years, namely from 1999 to 2016, in a scientific study. The findings of this study were as follows: published … + read more
The importance of biomedical innovation for European development and competitiveness
Farmmaindustria CEO Juan Yermo, European Commission health director Sandra Gallina and other EU political and business representatives analyze the role of incentives for research into new drugs. + read more
Problems of gradual introduction of innovations in medicines and their use in Spain
In Spain, a study estimates that a 10% increase in adherence rates for 4 high-incidence diseases would mean savings of more than €500 million in direct health care costs due to incremental drug innovations. + read more
The OptimIA project won the IV SEFH Innovation Forum
OptimIA, through the analysis of various variables and methods machine learning, will provide more evidence on the best use of drugs, predict response patterns and toxicity to anticipate reactions. + read more
Evinova, a new digital health business to accelerate innovation in life sciences
Evinova will operate as an independent medical technology unit within AstraZeneca. + read more
Innovations in medical care through PROMS at the Class III Center for Economics and Health Outcomes
This course edition, titled “Innovation through PROMS: Real-World Data,” aims to stimulate research by integrating real-world data to identify patterns, personalize treatments, and improve patient care. + read more
Surgical innovations improve treatment of liver cancer
Hepatocellular carcinoma is the most common liver cancer, with 60% to 90% of cases associated with cirrhosis. + read more